Literature DB >> 2016703

Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity.

P A Carrupt1, B Testa, A Bechalany, N el Tayar, P Descas, D Perrissoud.   

Abstract

Morphine 6-glucuronide, but not morphine 3-glucuronide, is a highly potent opiate receptor agonist. In fact, there is converging evidence that much of the analgesic effect occurring after morphine treatment in humans is due to this metabolite rather than to the parent drug. Yet glucuronides as a rule are considered as highly polar metabolites unable to cross the blood-brain barrier and rapidly excreted by the urinary and/or biliary routes. Here, we report that morphine 6-glucuronide, and to a lesser extent morphine 3-glucuronide, are far more lipophilic than predicted, and in fact not much less lipophilic than morphine itself. Force-field and quantum mechanical calculations indicate that the two glucuronides can exist in conformational equilibrium between extended and folded forms. The extended conformers, because they efficiently expose their polar groups, must be highly hydrophilic forms predominating in polar media such as water; in contrast, the folded conformers mask part of their polar groups, thus being more lipophilic and likely to predominate in media of low polarity such as biological membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016703     DOI: 10.1021/jm00108a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.

Authors:  R W Milne; R H Jensen; C Larsen; A M Evans; R L Nation
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Identifying potential binding modes and explaining partitioning behavior using flexible alignments and multidimensional scaling.

Authors:  M Feher; J M Schmidt
Journal:  J Comput Aided Mol Des       Date:  2001-12       Impact factor: 3.686

3.  [The role of morphine-6-glucuronide during longterm administration of morphine.].

Authors:  M Prokopek; A Ziegler
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 4.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

5.  Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

Authors:  R D Hain; A Hardcastle; C R Pinkerton; G W Aherne
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

6.  Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.

Authors:  R Xie; M R Bouw; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study.

Authors:  M J Barjavel; J M Scherrmann; H N Bhargava
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.

Authors:  Takashi Okura; Masanori Saito; Misato Nakanishi; Noriyuki Komiyama; Aki Fujii; Shizuo Yamada; Ryohei Kimura
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

Review 9.  The use of sedative agents in critically ill patients.

Authors:  A M Burns; M P Shelly; G R Park
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 10.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.